ITMCTR2000003705Not yet recruitingPhase 1
A multicenter clinical study of Ba qi ling mao formulation in the treatment of BCLC B / C stage of primary liver cancer
Shuguang Hospial Affiliated to Shanghai University of TCM0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 70 (—)
- Sex
- All
Inclusion Criteria
- •1. patients with primary liver cancer after radical resection (BCLC stage B, stage C);
- •2. aged 18 to 70 years;
- •3. The patients had not received systematic treatment before, including molecular targeted drug therapy, systemic chemotherapy, immunotherapy, etc;
- •4. Patients who are unable or unwilling to accept surgery or have disease progression after local treatment and cannot be operated again;
- •5. willing to accept Chinese medicine and/or integrated Chinese and western medicine treatment;
- •6. sign informed consent.
Exclusion Criteria
- •1. metastatic liver cancer patients, or concurrent with other cancer patients;
- •2. Patients with refractory ascites, hepatic encephalopathy, hepatorenal syndrome and other serious complications;
- •3. accompanied by heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract serious primary disease; Or mentally ill;
- •4. legally disabled persons, pregnant women or nursing women;
- •5. allergy or multiple drug allergy patients;
- •6. Currently participating in other clinical trials.
Investigators
Similar Trials
Not yet recruiting
Phase 1
Multicenter Clinical Observation of Bingqing Essential Oil in the Treatment of Vascular Pathway Related InfectionsVascular Pathway InfectionITMCTR1900002408The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Not yet recruiting
Phase 4
A Randomized Controlled Clinical Study of Ba-Bao-Dan Capsule in the Treatment of Gallbladder Polyps Below 10mmITMCTR2000003407Beijing Youan Hospital, Capital Medical University
Not yet recruiting
Phase 1
A randomized controlled trial of Ruanjian Qingmai Granule in the treatment of peripheral arterial diseaseperipheral arterial diseaseITMCTR2200005580shanghai TCM-Integrated Hospital
Completed
Phase 3
Multi-center phase ? clinical trial of Qinxiang Qingjie Oral Liquid for treating pediatric patients of acute upper respiratory infection with syndrome of heat in both exterior and interiorAcute upper respiratory infection with the syndrome of heat in both exterior and interiorITMCTR2200005578FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Not yet recruiting
Not Applicable
A Multi-Center Randomized Controlled Trial of Behavioral, Educational and Mixed Interventions for Improving Adherence to Glaucoma MedicationsEye DiseasesPACTR202108476131561BENJAMIN ABAIDOO160